Cargando…

Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms

Critiques of antidepressants in public spaces such as print media, blogs, social media, websites, and radio and television programs are now commonplace. Such critiques typically center on issues such as the side effects and risks of antidepressants, overblown claims of effectiveness, the fallacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sthamann, Erin, McMullen, Linda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649826/
https://www.ncbi.nlm.nih.gov/pubmed/34596489
http://dx.doi.org/10.1177/10497323211040768
_version_ 1784611080824160256
author Sthamann, Erin
McMullen, Linda M.
author_facet Sthamann, Erin
McMullen, Linda M.
author_sort Sthamann, Erin
collection PubMed
description Critiques of antidepressants in public spaces such as print media, blogs, social media, websites, and radio and television programs are now commonplace. Such critiques typically center on issues such as the side effects and risks of antidepressants, overblown claims of effectiveness, the fallacy of the chemical imbalance hypothesis, overprescribing, and the availability of equally or more effective nonmedication interventions for depression. In this article, we employ a discursive analysis to show how online commenters fashion a particular counter-argument to these critiques. Prominent in this counter-argument is that only “real” depression benefits from antidepressants, and that a “one-size-does-not-fit-all” understanding of these medications is needed. We argue that, while this nuanced counter-critique contains features that make it difficult to undermine, it simultaneously embeds many unanswered questions.
format Online
Article
Text
id pubmed-8649826
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-86498262021-12-08 Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms Sthamann, Erin McMullen, Linda M. Qual Health Res Research Articles Critiques of antidepressants in public spaces such as print media, blogs, social media, websites, and radio and television programs are now commonplace. Such critiques typically center on issues such as the side effects and risks of antidepressants, overblown claims of effectiveness, the fallacy of the chemical imbalance hypothesis, overprescribing, and the availability of equally or more effective nonmedication interventions for depression. In this article, we employ a discursive analysis to show how online commenters fashion a particular counter-argument to these critiques. Prominent in this counter-argument is that only “real” depression benefits from antidepressants, and that a “one-size-does-not-fit-all” understanding of these medications is needed. We argue that, while this nuanced counter-critique contains features that make it difficult to undermine, it simultaneously embeds many unanswered questions. SAGE Publications 2021-10-01 2021-12 /pmc/articles/PMC8649826/ /pubmed/34596489 http://dx.doi.org/10.1177/10497323211040768 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Research Articles
Sthamann, Erin
McMullen, Linda M.
Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms
title Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms
title_full Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms
title_fullStr Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms
title_full_unstemmed Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms
title_short Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms
title_sort critiquing the critique: resisting commonplace criticisms of antidepressants in online platforms
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649826/
https://www.ncbi.nlm.nih.gov/pubmed/34596489
http://dx.doi.org/10.1177/10497323211040768
work_keys_str_mv AT sthamannerin critiquingthecritiqueresistingcommonplacecriticismsofantidepressantsinonlineplatforms
AT mcmullenlindam critiquingthecritiqueresistingcommonplacecriticismsofantidepressantsinonlineplatforms